GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Inovio Biomedical Corporation (INO) [hlAlert]

Rating:
Buy INO
up 24.64 %

Inovio Biomedical Corporation (INO) rated Buy

Posted on: Tuesday,  Oct 9, 2007  9:25 AM ET by BWS Financial

BWS Financial rated Buy Inovio Biomedical Corporation (NASDAQ: INO) on 10/09/2007, when the stock price was $5.60. Since
then, Inovio Biomedical Corporation has gained 24.64% as of 01/05/2016's recent price of $6.98.
If you would have followed this BWS Financial's recommendation on INO, you would have gained 24.64% of your investment in 3010 days.

Inovio Biomedical Corporation (Inovio) is a San Diego-based biomedical company focused on the development of vaccines to prevent or treat cancers and chronic infectious diseases. Inovio develops deoxyribonucleic acid (DNA) delivery solutions based on electroporation, which uses brief, controlled electrical pulses to create temporary pores in cell membranes and enable increased cellular uptake of a useful biopharmaceutical. Once the DNA vaccine enters a cell, it can then express the proteins it was encoded to produce. Inovio has multiple systems designed to create different electroporation conditions for different applications consists of two documents: a pulse generator and an applicator that is inserted into selected tissue. The Company?s subsidiaries include Genetronics, Inc., Inovio AS and Inovio Asia Pte. Ltd. In June 2009, Inovio completed its merger with VGX Pharmaceuticals.

· BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology, healthcare and technology industries. · BWS Financial focuses on companies that hold much potential in their industries, either through their product pipeline or technological innovations. · BWS Financial’s strategy is not to only specialize in a particular group of stocks, but to also provide investors with insight into other ideas where there is considerable misvaluation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2007 9:25 AM Buy
None
5.60 14.00
as of 8/27/2015
1 Week up  7.55 %
1 Month down  -23.21 %
3 Months down  -12.64 %
1 YTD down  -39.82 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy